Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Blindness caused by glaucoma]

G K Krieglstein1

  • 1Universitäts-Augenklinik Köln.

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|December 1, 1993
PubMed
Summary
This summary is machine-generated.

Glaucoma is a leading cause of irreversible blindness globally. Early diagnosis and treatment, focused on lowering intraocular pressure (IOP), are crucial for preventing vision loss and blindness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Rebound tonometry and applanation tonometry during narcosis investigation of pediatric glaucoma].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2010
Same author

A prospective randomised trial of trabeculectomy using mitomycin C vs an ologen implant in open angle glaucoma.

Eye (London, England)·2010
Same author

Histopathology of an avascular filtering bleb after trabeculectomy with mitomycin-C.

Journal of glaucoma·2009
Same author

[Trabecular meshwork bypass surgery for glaucoma].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2009
Same author

Modern concepts in antiglaucomatous implant surgery.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2008
Same author

[Midterm patient satisfaction following mitomycin C-assisted trabeculectomy].

Klinische Monatsblatter fur Augenheilkunde·2008
Same journal

["DOG 2020 online" - for the first time in the von Graefe year].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2024
Same journal

[Are organ and co-cultures an alternative to animal models in ophthalmology?]

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Pediatric corneal opacities : Even small improvements provide lifelong help].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Myxoma of the conjunctiva].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Secondary open-angle glaucoma: uveitic secondary glaucoma, steroid-induced glaucoma, posttraumatic and postoperative glaucoma, tumor-related glaucoma and glaucoma due to elevated episcleral venous pressure].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Artificial intelligence in the management of anti-VEGF treatment: the Vienna fluid monitor in clinical practice].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
See all related articles

Area of Science:

  • Ophthalmology
  • Public Health
  • Epidemiology

Background:

  • Glaucoma is a primary cause of irreversible blindness worldwide, affecting both industrialized and developing nations.
  • Reliable epidemiological data are scarce due to the lack of universally applicable screening methods.
  • Open-angle glaucoma affects at least 1.7% of individuals over 40 in industrialized regions.

Purpose of the Study:

  • To review the global prevalence and impact of glaucoma.
  • To highlight the challenges in data collection and the influence of race on glaucoma types and risk.
  • To discuss the socioeconomic significance of glaucoma and the importance of early intervention.

Main Methods:

  • Literature review of epidemiological data on glaucoma prevalence.

Related Experiment Videos

  • Analysis of factors influencing glaucoma type frequency and blindness risk, including race.
  • Discussion of therapeutic efficacy and long-term success metrics for glaucoma management.

    • Main Results:

    • Prevalence of open-angle glaucoma is at least 1.7% in populations over 40.
    • Race significantly impacts glaucoma type and blindness risk, with higher risk in Black patients.
    • Blindness rates vary widely (5-33%), emphasizing the need for accessible early diagnosis and treatment.

    Conclusions:

    • Blindness from glaucoma is preventable through timely diagnosis and treatment, though economic factors in developing countries pose challenges.
    • Therapeutic success requires not only immediate intraocular pressure (IOP) reduction but also long-term visual function preservation.
    • Addressing the socioeconomic impact of glaucoma is vital for global public health strategies.